The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women.
Abstract
The effect of 12-month dehydroepiandrosterone (DHEA) replacement therapy has been evaluated in 14 60- to 70-yr-old women who received daily applications of a 10% DHEA cream. Vaginal epithelium maturation was stimulated by DHEA administration in 8 of 10 women who had a maturation value of zero at the onset of therapy, whereas a stimulatory effect was also seen in all three women who had an intermediate vaginal maturation index before therapy. The estrogenic effect of DHEA observed in the vagina was not observed in the endometrium, which remained atrophic in all women. Most interesting, the bone mineral density significantly increased at the hip from 0.744 +/- 0.021 to 0.759 +/- 0.025 g/cm2 after 12 months of treatment (P < 0.05). These changes in bone mineral density were associated with a significant 20.0% decrease (P < 0.01) in plasma bone alkaline phosphatase and a 28% decrease in the urinary hydroxyproline/creatinine ratio. A 2.1-fold increase over the control value (P < 0.01) in plasma osteocalcin was concomitantly observed. The present data describe for the first time a series of medically important beneficial effects of DHEA therapy in postmenopausal women through transformation of the precursor steroid DHEA into androgens and/or estrogens in specific peripheral intracrine tissues without significant adverse effects. The stimulatory effect on the vaginal epithelium in the absence of stimulation of the endometrium is of particular interest because it eliminates the need for progestin replacement therapy. On the other hand, the stimulatory effect on bone mineral density accompanied by an increase in serum osteocalcin, a marker of bone formation, suggests stimulation of bone formation by the androgenic action of DHEA, a finding of particular interest for both the prevention and treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“second, other studies of DHEA therapy in postmenopausal women (9) or aging (40,47) have also shown selective improvement in BMD at this site.”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“positive effects of DHEA replacement have been described on psychological well-being (6), body composition (7,8), and bone mineral density (BMD) (9) in older, normal adults.”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [9]
In the citing paper
“the absence of a stimulatory effect of DHEA on the human endometrium (73, 280) eliminates the need to administer a progestin to neutralize the stimulatory effect of estrogens in this tissue.”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“Bone mass density was increased by 2.3% at the hip, 3.75% at the hip Ward's triangle, and 2.2% at the lumbar spine level (all P Ͻ 0.05; Ref. 280).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“women, at menopause, are not only deprived from estrogens because of a rapid loss of ovarian activity but also have been deprived from androgens for a longer period because of a progressive decrease of serum DHEA levels starting quite a few years before menopause.”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“the estrogenic stimulatory effect observed in the vagina was not found in the endometrium, which remained completely atrophic in all women after 12 months of DHEA treatment (280).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“We have also determined that the serum levels of DHEA using a 10% cream (280) were comparable to the ones obtained after daily oral administration of 100 mg of DHEA (our unpublished data).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Determination of serum creatinine by a direct colorimetric method
Heinegård, D. K., & Tiderström, G. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90466-x · Cited by 724
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713
Self-citationA prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.
Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152405 · Cited by 681
The Functions of Corticosteroid-Binding Globulin and Sex Hormone-Binding Globulin: Recent Advances*
Rosner, W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-1-80 · Cited by 560
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
Davis, S. R., McCloud, P., Strauss, B. J., & Burger, H. (1995) · Maturitas · doi:10.1016/0378-5122(94)00898-h · Cited by 534
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–291 of 291
Dehydroepiandrosterone replacement therapy
Arlt, W., & Allolio, B. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00005 · Cited by 11
DHEA supplementation improves endometrial HOXA-10 mRNA expression in poor responders
Çelik, Ö., Acet, M., İmren, A., Çelik, N., Erşahin, A., Aktün, L. H., Otlu, B., Çelik, S., Çalışkan, E., & Ünlü, C. (2017) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2017.0054 · Cited by 11
Straub, R. H., Schölmerich, J., & Zietz, B. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070004 · Cited by 10
Dehydroepiandrosterone Supplements: Bringing Sense to Sensational Claims
Nippoldt, T. B. (1998) · Endocrine Practice · doi:10.4158/ep.4.2.106 · Cited by 9
ORWOLL, E. S. (1999) · Elsevier eBooks · doi:10.1016/b978-012528640-4/50014-9 · Cited by 8
Sex differences in skeletal development
Fitzpatrick, L. A. (2004) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)34016-0 · Cited by 7
Williams, B. R., & Cho, J. S. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.04.006 · Cited by 7
DHEA: Biology and Use in Therapeutic Intervention
Buster, J. E., & Casson, P. R. (2000) · Elsevier eBooks · doi:10.1016/b978-012453790-3/50045-7 · Cited by 7
Some reflections on the endocrinology of the aging male
Vermeulen, A. (1998) · The Aging Male · doi:10.3109/13685539809146103 · Cited by 7
Prevalence of and recent developments in female sexual dysfunction
Shabsigh, R. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0051-9 · Cited by 6
Watanabe, T., Ashida, K., Goto, K., Nawata, H., Takayanagi, R., Yanase, T., & Nomura, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.131 · Cited by 6
Langley, E., Velázquez‐Cruz, R., Parra-Torres, A. Y., & Enríquez, J. (2018) · Endocrine Research · doi:10.1080/07435800.2018.1559185 · Cited by 6
Dehydroepiandrosterone treatment attenuates oestrogen-induced pituitary hyperplasia
Suárez, C. A., Tornadu, I. A. G., Khalil, W. K. B., & Becú‐Villalobos, D. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740447 · Cited by 6
Schlienger, J.-L., Perrin, A., & Goichot, B. (2002) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(02)00591-x · Cited by 6
Androgen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 6
Yanase, T. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.156 · Cited by 5
Is Bio-Identical Hormone Therapy Fact or Fairy Tale?
Francisco, L. (2003) · The Nurse Practitioner · doi:10.1097/00006205-200307000-00008 · Cited by 5
Neuropsychiatric Effects of Dehydroepiandrosterone (DHEA)
Wolkowitz, O. M., & Reus, V. I. (2011) · De Gruyter eBooks · doi:10.1515/9783110811162.271 · Cited by 5
Kocis, P. T. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060100 · Cited by 5
Li, S., Li, W., Chang, L., Wan, J., Chen, S., Zhang, X., He, Q., & Liu, M. R. (2024) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-024-01511-9 · Cited by 4
Yen, S. S. C. (2000) · Rejuvenation Research · doi:10.1089/rej.1.2000.3.315 · Cited by 4
Dehydroepiandrosterone and androstenedione
Allolio, B., Arlt, W., & Hahner, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.021 · Cited by 5
Effects of Androgens on Bone in Men and Women
McGriff-Lee, N. J., Kalantaridou, S., Pucino, F., & Calis, K. A. (2005) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1385/bmm:3:1:051 · Cited by 4
Mischley, L. K., Nicolai, P. J., & Gaby, A. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00085-7 · Cited by 4
Can DHEA be used to prevent bone loss and osteoporosis?
Marcelli, C. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(02)00002-7 · Cited by 4
Anti-Aging: Mythen und Fakten zur Diagnose und Therapie
Zech, N. H. (2004) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000076864 · Cited by 4
Potential Therapeutic Effects of Prescribed and Over-the-Counter Androgens in Women
Khorram, O. (2001) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200112000-00025 · Cited by 4
Dehydroepiandrosterone and Pregnenolone
Sih, R., Kamel, H. K., Horani, M. H., & Morley, J. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_15 · Cited by 3
Berger, L., Elalfy, M., Martel, C., & Labrie, F. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.026 · Cited by 3
Self-citationLabrie, F. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.064 · Cited by 3
Self-citationKrząścik, P., Zajda, M., & Majewska, M. D. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.12.012 · Cited by 3
Adrenopause und Dehydroepiandrosteron: Pharmakotherapie versus Substitution
Römmler, A. (2003) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000069165 · Cited by 3
Lee, S. Y., Myung, S. C., Lee, M. Y., Kim, T., Kim, S. C., Kim, K. D., Park, S. H., & Kim, W. Y. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01397.x · Cited by 3
Rabe, T., Hj, A., Albring, C., Bachmann, A., Bitzer, J., Blume‐Peytavi, U., Egarter, C., Hinney, B., Kentenich, H., König, K. G., et al. (2016) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
Breast Cancer Risks and Prevention
Lanfranchi, A., & BRIND, J. L. (2007) · Cited by 3
Bioidentical hormones in the treatment of osteoporosis.
Boomsma, D. M. (2001) · PubMed · Cited by 3
Hughes, I. A., & Chatterjee, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00105-0 · Cited by 3
Dehydroepiandrosterone and Pregnenolone
Tariq, S. H., Kamel, H. K., & Morley, J. E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-375-0_18 · Cited by 3
Portman, D. J., Archer, D. F., Martel, C., & Labrie, F. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000638 · Cited by 3
Self-citationDie Rolle des Schlüsselhormons DHEA
Römmler, A., & Römmler-Zehrer, J. (2013) · gynäkologie + geburtshilfe · doi:10.1007/s15013-013-0276-9 · Cited by 2
Belaisch, J. (2002) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(02)00490-3 · Cited by 2
The clinical use of dehydroepiandrosterone in postmenopausal women.
Bramwell, B. L. (2010) · PubMed · Cited by 2
Impact of circulating dehydroepiandrosterone on androgen formation in women
Labrie, F. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182146d7f · Cited by 2
Self-citationRationale for Treating Hypoandrogenism in Women
Davis, S. R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_19 · Cited by 2
Endocrine Complications Following Hematopoietic Cell Transplantation
KANDEEL, F. R., & Salehian, B. (2015) · doi:10.1002/9781118416426.ch97 · Cited by 2
Herbals and Other Dietary Supplements for Premenstrual Syndrome and Menopause
Chavez, M. L., & Spitzer, M. F. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020101-10 · Cited by 2
Leidenberger, F. A. (2005) · Springer eBooks · doi:10.1007/3-540-26406-x_17 · Cited by 2
Androgens and Androgenic Progestins
Khosla, S. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50077-5 · Cited by 2
Chapter 22 Dehydroepiandrosterone
Schiechl, G., & Straub, R. H. (2008) · Technical report · doi:10.1016/s1571-5078(07)00222-x · Cited by 1
Hughes, I. A., & Chatterjee, K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00104-0 · Cited by 1
Hormontherapie und Anti-Aging: Gibt es eine Indikation?
Heutling, D., & Lehnert, H. (2008) · Der Internist · Cited by 1
Sherman, S. (1999) · Elsevier eBooks · doi:10.1016/b978-012098655-2/50004-1 · Cited by 1
Leidenberger, F. A., & Rabe, T. (2009) · Springer eBooks · doi:10.1007/978-3-540-89760-6_18 · Cited by 1
LA PLACE DES ANDROGENES CHEZ LA FEMME MENOPAUSEE
de Muylder, X. (2002) · Acta Clinica Belgica · doi:10.1179/acb.2002.039 · Cited by 1
Bardóczy, Z., Kocsis, I., Treszl, A., Tulassay, T., Vásárhelyi, B., & Szathmári, M. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0632-5 · Cited by 1
Female Androgen Insufficiency Syndrome
Garcia-Banigan, D. C., & Guay, A. T. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7234-3266-1.50024-3 · Cited by 1
Davis, S. R. (2000) · Elsevier eBooks · doi:10.1016/b978-012453790-3/50032-9 · Cited by 1
ORWOLL, E. S. (1999) · Elsevier eBooks · doi:10.1016/b978-012098655-2/50045-4 · Cited by 1
Endokrinologische Aspekte der Hautalterung
Fritz, K. (2008) · Springer eBooks · doi:10.1007/978-3-540-76821-0_4
Fatiga en esclerosis múltiple: aspectos clínicos, biológicos y radiológicos
Lara, N. T. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Androgen Deficiency and Abnormality in Women
Jang, C., & Davis, S. R. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1161-8_20
Bednarek-Tupikowska, G., Kuryszko, J. J., Kosowska, B., Bohdanowicz-Pawlak, A., & Milewicz, A. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167561
Fontanges, É., Fontana, A., & Delmas, P. D. (2003) · Revue du Rhumatisme · doi:10.1016/j.rhum.2003.02.001
Receptor selectivity, enzymes and tissue specificity
Mijatovic, V. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00185-7
DHEA et pathologie ostéoarticulaire
Cormier, C., Souberbielle, J., & Kahan, A. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00211-3
Tutera, G., & GAMBRELL, D. R. (2009) · Maturitas · doi:10.1016/s0378-5122(09)70206-3
Lebrun, C. E. I. (2008) · EUR Research Repository (Erasmus University Rotterdam)
Supplement. Anti-apoptotic effect of dehydroepiandrosterone and its role in an aging society.
Yamada, Y., Nakajima, A., & Sekihara, H. (2004) · Internal medicine · doi:10.2169/internalmedicine.43.158
[Therapy with dehidroepiandrosterone improves symptoms in perimenopausal women].
Valencia, M. H., Ángeles, L., Saucedo, R., Basurto, L., & Zárate, A. (2005) · PubMed
DHEA: A Novel Treatment for Osteoporosis?
GHARIB, S. D. (1997) · Journal watch · doi:10.1056/wh199711010000015
La DHEA est-elle un traitement préventif de la perte osseuse et de l’ostéoporose ?
Marcelli, C. (2003) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00002-9
佳彦, 山., Nakajima, J., & Sekihara, H. (2003) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.92.1705
Cáncer de mama: Riesgos y Prevención Cuarta edición
Lanfranchi, A., & BRIND, J. L. (2007)
Fortich, Á., Alvis‐Guzmán, N., & Méndez, D. (2004)
Androgens in Male Sexual Physiology
McMahon, C. G. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7234-3266-1.50010-3
Alternative Therapy: Dehydroepiandrosterone for Menopausal Hormone Replacement
Dudley, P. S., & Buster, J. E. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50071-5
DHEA as a Putative Replacement Therapy in the Elderly
Genazzani, A. D., & Lanzoni, C. (2011) · CRC Press eBooks · doi:10.1201/b11019-4
Davis, S. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50068-5
DHEA, The Precursor of Androgens and Estrogens in Peripheral Tissues in the Human: Intracrinology
Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., & Lin, S. (2011) · De Gruyter eBooks · doi:10.1515/9783110811162.299
Self-citationBarton, D. L., Bardia, A., & Loprinzi, C. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-291-5_13
Stanczyk, F. Z. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000639
Szybala, C., Szybala, M. P., Mischley, L. K., Nicolai, P., & Gaby, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00074-1
Goeckenjan, M., Böhm, M. M., & Strowitzki, T. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_11
Hartkamp, A. (2014) · Utrecht University Repository (Utrecht University)
敏彦, 柳. (2003) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.92.1701
Bernaldez, J. M., Burgess, E. R., Martinez, R., & Peñalver, M. (2026) · Cureus · doi:10.7759/cureus.106713
Dehydroepiandrosterone (DHEA) and Glucocorticoids‐to‐DHEA(S) Ratio
Whitham, J. C., & Miller, L. J. (2026) · Wiley eBooks · doi:10.1002/9781394182237.ch10
Metadata
- Authors
- Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Labrie, Fernand
- ORCID
- Candas, Bernard
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-10
- Volume
- 82
- Issue
- 10
- Pages
- 3498-3505
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1970025509
- Cited by
- 292
- References
- 71
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 10
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- dehydroepiandrosterone, DHEA replacement therapy, postmenopausal women, bone mineral density, endometrial atrophy, osteocalcin, bone-specific alkaline phosphatase, urinary hydroxyproline, osteoporosis prevention, androgenic effects, estrogenic effects
- MeSH terms
- Aged, Atrophy, Bone and Bones, Bone Resorption, Dehydroepiandrosterone, Endometrium, Female, Humans, Middle Aged, Osteogenesis, Sebum, Sex Hormone-Binding Globulin, Vagina, Biomarkers, Bone Density, Bone Remodeling, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
